HOME >> MEDICINE >> NEWS
The lancet infectious diseases (TLID) October press release

Bacterial eradication in the treatment of otitis media

Otitis media (middle-ear infection) is a common infectious disease of early childhood; an estimated 20 million cases occur in the USA annually. This review assesses the impact of antibacterial treatment, commenting on how clinicians may become mislead by drug treatment as otitis media often resolves naturally within a few days of infection; the growing problem of widespread antibiotic resistance is also limiting the effectiveness of many therapeutic treatments for the disorder.

Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa?

This review calls for the re-introduction of strategies to target the larvael stage of the anopheles mosquito as part of the global 'Roll Back Malaria' campaign.

OTHER REVIEWS:

Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections

This systematic review and meta-analysis of randomised controlled trials involving more than 5000 women provides further evidence that a cheap and commonly used spermicide gel is not effective in reducing HIV-1 and other sexually transmitted infections.

Staphylococcus aureus disease in drug users
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
4-Oct-2002


Page: 1

Related medicine news :

1. The lancet specialty journals press releases
2. Physicians call for increased funding for federal infectious disease programs
3. Mailman School of Public Health researchers develop infectious disease diagnostic tool
4. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
5. NIAID launches program to improve medical tools against emerging infectious diseases
6. Study suggests better use of web could improve infectious disease reporting
7. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
8. Two centres for infectious diseases established
9. Expert guide to infectious diseases published
10. Stress may increase susceptibility to infectious disease
11. First mouse model for multiple system atrophy points to new treatment targets for brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
Cached News: